Press Release Feb 17, 2026 Lumanity Becomes First Life Sciences Value Demonstration Partner to Achieve ISO 42001 Certification, Setting a New Standard for Responsible AI in Life Sciences
Press Release Feb 17, 2026 Lumanity Becomes First Life Sciences Value Demonstration Partner to Achieve ISO 42001 Certification, Setting a New Standard for Responsible AI in Life Sciences
Case Study Sep 7, 2022 Cell Therapy Framework to Inform Positioning and Development Strategy for a Top Oncology-focused Global Biopharma
Case Study Jul 28, 2022 Development of a Go-To-Market (GTM) Strategy to Address a Rapidly Evolving Market Landscape
Case Study Jun 29, 2022 From Discovery to Proof of Concept: Early Asset Framework Mapping in Commercial Strategy Development
Case Study Jun 14, 2022 Platform Assessment, Indication Prioritization & TPP Development to Inform Development Plan and Competitive Differentiation
Case Study Jun 12, 2022 Clinical Validation, TPP Refinement and Value Assessment of iPSC derived Cell Therapies
Case Study May 12, 2022 Strategic Development of Gene-Editing Platform Technology in Rare Disease Space
Case Study Apr 11, 2022 Top Multinational Pharma Interested in Assessing/Onboarding ACT and/or Other IO Modalities; IO Landscape, Portfolio Gap Analysis, and BD Strategy Assessment
Case Study Mar 25, 2022 Multivariate Prioritization of Putative Targets, Indications and Specific Therapeutic Modalities
